Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 1

Results: 15

The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 13, doi. 10.1007/s00262-017-2057-0

By:

Khan, Mohammad W.;
Saadalla, Abdulrahman;
Ewida, Ahmed H.;
Al-Katranji, Khalid;
Al-Saoudi, Ghadier;
Giaccone, Zachary T.;
Gounari, Fotini;
Zhang, Ming;
Frank, David A.;
Khazaie, Khashayarsha

Publication type:

Article

Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 47, doi. 10.1007/s00262-017-2059-y

By:

Hebb, Jonathan P. O.;
Mosley, Adriane R.;
Vences-Catalán, Felipe;
Rajasekaran, Narendiran;
Rosén, Anna;
Ellmark, Peter;
Felsher, Dean W.

Publication type:

Article

Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 113, doi. 10.1007/s00262-017-2060-5

By:

Kawashima, Atsunari;
Kanazawa, Takayuki;
Goto, Kumiko;
Matsumoto, Mitsunobu;
Morimoto-Okazawa, Akiko;
Iwahori, Kota;
Ujike, Takeshi;
Nagahara, Akira;
Fujita, Kazutoshi;
Uemura, Motohide;
Nonomura, Norio;
Wada, Hisashi

Publication type:

Article

Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 39, doi. 10.1007/s00262-017-2061-4

By:

Diem, Stefan;
Hasan Ali, Omar;
Ackermann, Christoph J.;
Bomze, David;
Koelzer, Viktor H.;
Jochum, Wolfram;
Speiser, Daniel E.;
Mertz, Kirsten D.;
Flatz, Lukas

Publication type:

Article

Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 61, doi. 10.1007/s00262-017-2062-3

By:

Kashima, Jumpei;
Okuma, Yusuke;
Shimizuguchi, Ryoko;
Chiba, Kazuro

Publication type:

Article

Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 67, doi. 10.1007/s00262-017-2063-2

By:

Teke, Kerem;
Guzel, Nil;
Uslubas, Ali Kemal;
Kasap, Murat;
Yilmaz, Hasan;
Akpinar, Gurler;
Yildiz, Demir Kursat;
Dillioglugil, Ozdal

Publication type:

Article

HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 79, doi. 10.1007/s00262-017-2064-1

By:

Wang, Jiajun;
Liu, Li;
Qu, Yang;
Xi, Wei;
Xia, Yu;
Bai, Qi;
Xiong, Ying;
Long, Qilai;
Xu, Jiejie;
Guo, Jianming

Publication type:

Article

Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 101, doi. 10.1007/s00262-017-2067-y

By:

Belyaev, Nikolai N.;
Abdolla, Nurshat;
Perfilyeva, Yuliya V.;
Ostapchuk, Yekaterina O.;
Krasnoshtanov, Vladimir K.;
Kali, Aikyn;
Tleulieva, Raikhan

Publication type:

Article

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 89, doi. 10.1007/s00262-017-2068-x

By:

Fucikova, Jitka;
Podrazil, Michal;
Jarolim, Ladislav;
Bilkova, Pavla;
Hensler, Michal;
Becht, Etienne;
Gasova, Zdenka;
Klouckova, Jana;
Kayserova, Jana;
Horvath, Rudolf;
Fialova, Anna;
Vavrova, Katerina;
Sochorova, Klara;
Rozkova, Daniela;
Spisek, Radek;
Bartunkova, Jirina

Publication type:

Article

Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 127, doi. 10.1007/s00262-017-2071-2

By:

Franzen, Daniel;
Schad, Karin;
Kowalski, Benedikt;
Clarenbach, Christian F.;
Stupp, Roger;
Dummer, Reinhard;
Kohler, Malcolm

Publication type:

Article

Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 141, doi. 10.1007/s00262-017-2072-1

By:

Balatoni, Tímea;
Mohos, Anita;
Papp, Eszter;
Sebestyén, Tímea;
Liszkay, Gabriella;
Oláh, Judit;
Varga, Anita;
Lengyel, Zsuzsanna;
Emri, Gabriella;
Gaudi, István;
Ladányi, Andrea

Publication type:

Article

Quantification of altered tissue turnover in a liquid biopsy: a proposed precision medicine tool to assess chronic inflammation and desmoplasia associated with a pro-cancerous niche and response to immuno-therapeutic anti-tumor modalities.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 1, doi. 10.1007/s00262-017-2074-z

By:

Willumsen, Nicholas;
Thomsen, Louise B.;
Bager, Cecilie L.;
Jensen, Christina;
Karsdal, Morten A.

Publication type:

Article

2nd Symposium on Advances in Cancer Immunology and Immunotherapy, December 15-17, 2016, Athens, Greece.

Published in:

2018

By:

Samara, Pinelopi;
Kotsakis, Athanasios;
Tsitsilonis, Ourania;
Georgoulias, Vassilis;
Pawelec, Graham;
Baxevanis, Constantin N.

Publication type:

Report

Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 25, doi. 10.1007/s00262-017-2055-2

By:

Nowakowska, Paulina;
Romanski, Annette;
Miller, Nicole;
Odendahl, Marcus;
Bonig, Halvard;
Zhang, Congcong;
Seifried, Erhard;
Wels, Winfried S.;
Tonn, Torsten

Publication type:

Article

Safety of shortened infusion times for combined ipilimumab and nivolumab.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 135, doi. 10.1007/s00262-017-2075-y

By:

Gassenmaier, Maximilian;
Lipp, Hans-Peter;
Scheu, Alexander;
Wagner, Nikolaus Benjamin;
Kofler, Lukas;
Mueller, Alisa;
Doecker, Dennis;
Eigentler, Thomas Kurt;
Garbe, Claus;
Forschner, Andrea

Publication type:

Article